Doesn't seem like they have enough data for safety.
Concerns seemed to be around not enough long term data, not enough data from different subsets of the population, people with different antibodies to non-specific things like polyethylene glycols used in vaccines, trial populations used were extremely healthy, did not have histories of autoimmune or other disorders, long term affects on fertility, etc.